Current Science Group

Current Science Group is a London-based organization of independent companies that develop innovative information services and software for the life science and healthcare sectors. Founded by entrepreneur Vitek Tracz, the group is recognized for its 'incubate and exit' strategy, having launched and sold industry-defining entities such as BioMed Central, Current Drugs, and the 'Current Opinion' journal series. The group's portfolio has historically focused on open-access publishing, drug discovery databases, and research evaluation tools. While many of its most famous subsidiaries have been acquired by major publishers like Springer Nature and Taylor & Francis, the group continues to influence the scientific communication landscape through its remaining ventures and new initiatives. It is widely credited with pioneering the commercial open-access model for scientific research.